• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核苷酸结合寡聚化结构域2调节特定的Toll样受体途径以诱导细胞因子释放。

Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.

作者信息

Netea Mihai G, Ferwerda Gerben, de Jong Dirk J, Jansen Trees, Jacobs Liesbeth, Kramer Matthijs, Naber Ton H J, Drenth Joost P H, Girardin Stephen E, Kullberg Bart Jan, Adema Gosse J, Van der Meer Jos W M

机构信息

Department of Medicine, Radboud University Medical Center Nijmegen, The Netherlands.

出版信息

J Immunol. 2005 May 15;174(10):6518-23. doi: 10.4049/jimmunol.174.10.6518.

DOI:10.4049/jimmunol.174.10.6518
PMID:15879155
Abstract

The recognition of peptidoglycan by cells of the innate immune system has been controversial; both TLR2 and nucleotide-binding oligomerization domain-2 (NOD2) have been implicated in this process. In the present study we demonstrate that although NOD2 is required for recognition of peptidoglycan, this leads to strong synergistic effects on TLR2-mediated production of both pro- and anti-inflammatory cytokines. Defective IL-10 production in patients with Crohn's disease bearing loss of function mutations of NOD2 may lead to overwhelming inflammation due to a subsequent Th1 bias. In addition to the potentiation of TLR2 effects, NOD2 is a modulator of signals transmitted through TLR4 and TLR3, but not through TLR5, TLR9, or TLR7. Thus, interaction between NOD2 and specific TLR pathways may represent an important modulatory mechanism of innate immune responses.

摘要

天然免疫系统细胞对肽聚糖的识别一直存在争议;Toll样受体2(TLR2)和核苷酸结合寡聚化结构域2(NOD2)都与这一过程有关。在本研究中,我们证明,虽然识别肽聚糖需要NOD2,但这会对TLR2介导的促炎和抗炎细胞因子的产生产生强烈的协同效应。患有克罗恩病且携带功能丧失性NOD2突变的患者,其白细胞介素-10产生缺陷,可能会因随后的Th1偏向而导致炎症失控。除了增强TLR2的作用外,NOD2还是通过TLR4和TLR3(而非TLR5、TLR9或TLR7)传递的信号的调节剂。因此,NOD2与特定TLR途径之间的相互作用可能代表了天然免疫反应的一种重要调节机制。

相似文献

1
Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.核苷酸结合寡聚化结构域2调节特定的Toll样受体途径以诱导细胞因子释放。
J Immunol. 2005 May 15;174(10):6518-23. doi: 10.4049/jimmunol.174.10.6518.
2
NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.NOD2介导由TLR2配体诱导的抗炎信号:对克罗恩病的意义。
Eur J Immunol. 2004 Jul;34(7):2052-9. doi: 10.1002/eji.200425229.
3
Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.Toll样受体4和含Toll-IL-1受体结构域的衔接蛋白(TIRAP)/髓样分化蛋白88衔接蛋白样分子(Mal)有助于巨噬细胞中白细胞介素-6的最大表达。
J Immunol. 2002 Nov 15;169(10):5874-80. doi: 10.4049/jimmunol.169.10.5874.
4
Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.在遗传性克罗恩病中,Toll样受体9(TLR9)与核苷酸结合寡聚化结构域样受体2(NOD2)先天免疫反应之间的协同作用丧失。
Gut. 2005 Nov;54(11):1553-7. doi: 10.1136/gut.2005.065888. Epub 2005 May 31.
5
Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.胞壁酰二肽通过成骨细胞中核苷酸结合寡聚化结构域2介导的信号传导增强脂多糖、白细胞介素-1α和肿瘤坏死因子-α诱导的破骨细胞形成。
J Immunol. 2005 Aug 1;175(3):1956-64. doi: 10.4049/jimmunol.175.3.1956.
6
Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.胞壁酰二肽和含二氨基庚二酸的去胞壁酰肽分别与化学合成的Toll样受体激动剂联合,以NOD2和NOD1依赖的方式,协同诱导培养的人单核细胞产生白细胞介素-8。
Cell Microbiol. 2005 Jan;7(1):53-61. doi: 10.1111/j.1462-5822.2004.00433.x.
7
An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.巨噬细胞中的血管生成开关,涉及Toll样受体2、4、7和9与腺苷A(2A)受体之间的协同作用。
Am J Pathol. 2003 Aug;163(2):711-21. doi: 10.1016/S0002-9440(10)63698-X.
8
IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells.伴随TLR2刺激释放的白细胞介素-10阻断了人类树突状细胞中由TLR4或TLR3特异性诱导的一部分Th1细胞因子的诱导。
J Immunol. 2004 Dec 15;173(12):7548-55. doi: 10.4049/jimmunol.173.12.7548.
9
Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.配体调节嵌合受体方法揭示了Toll样受体独特的亚细胞定位和信号特性。
J Biol Chem. 2004 Apr 30;279(18):19008-17. doi: 10.1074/jbc.M311618200. Epub 2004 Feb 19.
10
Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.Nod1和Nod2激动剂与Toll样受体激动剂对人树突状细胞产生白细胞介素-12和1型辅助性T细胞的协同作用。
Infect Immun. 2005 Dec;73(12):7967-76. doi: 10.1128/IAI.73.12.7967-7976.2005.

引用本文的文献

1
Muropeptides and muropeptide transporters impact on host immune response. 肽聚糖及其转运蛋白影响宿主免疫反应。
Gut Microbes. 2024 Jan-Dec;16(1):2418412. doi: 10.1080/19490976.2024.2418412. Epub 2024 Oct 22.
2
Distinctive Immune Signatures Driven by Structural Alterations in Desmuramylpeptide NOD2 Agonists.结构修饰的 NOD2 激动剂诱导的独特免疫特征。
J Med Chem. 2024 Oct 10;67(19):17585-17607. doi: 10.1021/acs.jmedchem.4c01577. Epub 2024 Sep 29.
3
NOD1, NOD2, and NLRC5 Receptors in Antiviral and Antimycobacterial Immunity.
抗病毒和抗分枝杆菌免疫中的NOD1、NOD2和NLRC5受体
Vaccines (Basel). 2022 Sep 7;10(9):1487. doi: 10.3390/vaccines10091487.
4
Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their Adjuvant Activity.结构精细调整脱酰基肽 NOD2 激动剂定义了它们的佐剂活性。
J Med Chem. 2021 Jun 10;64(11):7809-7838. doi: 10.1021/acs.jmedchem.1c00644. Epub 2021 May 27.
5
IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent.2 型固有淋巴细胞(ILC2)的 IL-6 效应功能依赖于 NOD2。
Sci Immunol. 2021 May 21;6(59). doi: 10.1126/sciimmunol.abe5084.
6
The First Contact of Human Dendritic Cells With Reveals Response to Virus as an Unexplored Central Pathway.人类树突状细胞与 病毒的初次接触揭示了病毒反应是一条未被探索的中心途径。
Front Immunol. 2021 Apr 9;12:638020. doi: 10.3389/fimmu.2021.638020. eCollection 2021.
7
New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses.新型嵌合 TLR7/NOD2 激动剂是一种有效的黏膜免疫佐剂。
EBioMedicine. 2020 Aug;58:102922. doi: 10.1016/j.ebiom.2020.102922. Epub 2020 Jul 30.
8
Novel Clinical Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis.基于小鼠对脂寡糖致敏的新型临床感染模型,脂寡糖是人类弯曲菌病中触发先天免疫反应的主要细菌因子。
Microorganisms. 2020 Mar 28;8(4):482. doi: 10.3390/microorganisms8040482.
9
Genetic epidemiology of the Alpine ibex reservoir of persistent and virulent brucellosis outbreak.持久和高毒力布鲁氏菌病暴发的阿尔卑斯野山羊遗传流行病学研究。
Sci Rep. 2020 Mar 10;10(1):4400. doi: 10.1038/s41598-020-61299-2.
10
Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.组织型纤溶酶原激活物选择性抑制 CSF-1 分化的巨噬细胞中的多种 toll 样受体。
PLoS One. 2019 Nov 7;14(11):e0224738. doi: 10.1371/journal.pone.0224738. eCollection 2019.